Eikon Therapeutics appoints Ching-Pin Chang as EVP and CSO
Eikon Therapeutics appointed Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.